Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000046

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 26, 2017
Accepted (ET)
Apr 27, 2017 · 1:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 26, 2017P1,000$0.072A20,396,949D
Common StockApr 26, 2017P1,000$0.073A20,397,949D
Common StockApr 26, 2017P1,000$0.0724A20,398,949D
Common StockApr 26, 2017P1,000$0.0729A20,399,949D
Common StockApr 26, 2017P1,000$0.0729A20,400,949D
Common StockApr 26, 2017P1,000$0.0749A20,401,949D
Common StockApr 26, 2017P1,000$0.0749A20,402,949D
Common StockApr 26, 2017P1,000$0.073A20,403,949D
Common StockApr 26, 2017P1,000$0.075A20,404,949D
Common StockApr 26, 2017P500$0.0749A20,405,449D
Common StockApr 26, 2017P1,000$0.0749A20,406,449D
Common StockApr 26, 2017P1,000$0.0729A20,407,449D
Common StockApr 26, 2017P1,000$0.073A20,408,449D
Common StockApr 26, 2017P1,000$0.073A20,409,449D
Common StockApr 26, 2017P1,000$0.07A20,410,449D
Common StockApr 26, 2017P1,000$0.0716A20,411,449D
Common StockApr 26, 2017P1,000$0.0716A20,412,449D
Common StockApr 26, 2017P1,000$0.072A20,413,449D
Common StockApr 26, 2017P1,000$0.072A20,414,449D
Common StockApr 26, 2017P1,000$0.072A20,415,449D
Common StockApr 26, 2017P1,000$0.072A20,416,449D
Common StockApr 26, 2017P1,000$0.072A20,417,449D
Common StockApr 26, 2017P1,000$0.072A20,418,449D
Common StockApr 26, 2017P1,000$0.072A20,419,449D
Common StockApr 26, 2017P1,000$0.072A20,420,449D

Table II — derivative securities

No Table II lines on this filing.